Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
Pubblicato in: | Nature Cancer 4(2023)1, S. 96-107 |
---|---|
Autori principali: | Denkinger, Claudia M. (Autore), Janssen, Maike (Autore), Pohle, Thorsten (Autore), Ruhe, Matthias (Autore) |
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
2023
|
Soggetti: | |
Accesso online: | https://doi.org/10.1038/s43018-022-00503-w |
Documenti correlati: | In:
Nature Cancer |
Documenti analoghi
-
Phenobarbitalintoxikation in suizidaler Absicht : kontinuierliche venovenöse Hämodialyse als effektive Therapie
di: Ruhe, Matthias, et al.
Pubblicazione: (2016) -
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders : a cohort study from Germany
di: Kümpfel, Tania, et al.
Pubblicazione: (2020) -
Impact of physical or sexual childhood abuse on plasma DHEA, DHEA-S and cortisol in a low-dose dexamethasone suppression test and on cardiovascular risk parameters in adult patients with major depression or anxiety disorders
di: Kellner, Michael, et al.
Pubblicazione: (2018) -
Transiente globale Amnesie und Tako-Tsubo-Kardiomyopathie - Zufall oder logische Folge?
di: Grautoff, Steffen, et al.
Pubblicazione: (2012) -
Effects of 35% carbon dioxide (CO 2) inhalation in patients with post-traumatic stress disorder (PTSD) : a double-blind, randomized, placebo-controlled, cross-over trial
di: Kellner, Michael, et al.
Pubblicazione: (2018)